Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY18.90 CNY
Change Today 0.00 / 0.00%
Volume 0.0
300158 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:05 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

shanxi zhendong pharmaceut-a (300158) Snapshot

Open
--
Previous Close
CNY18.90
Day High
--
Day Low
--
52 Week High
04/13/15 - CNY19.94
52 Week Low
12/31/14 - CNY12.80
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
CNY0.15
Shares Outstanding
288.0M
EX-Date
07/24/15
P/E TM
--
Dividend
CNY0.10
Dividend Yield
0.53%
Current Stock Chart for SHANXI ZHENDONG PHARMACEUT-A (300158)

Related News

No related news articles were found.

shanxi zhendong pharmaceut-a (300158) Related Businessweek News

No Related Businessweek News Found

shanxi zhendong pharmaceut-a (300158) Details

Shanxi Zhendong Pharmaceutical Co., Ltd researches, develops, manufactures, and distributes Chinese medicine preparations and chemical pharmaceutical preparations in China. The company offers injections, tablets, capsules, granules, pharmaceutical ingredients, pills, and others. Its principal products include Yanshu, norfloxacin, Shuxuening, and Guanxinning injections; sodium amoxicillin, sodium flucloxacillin, cefathiamidine, and riboflavin sodium phosphate for injection; and other products. The company is based in Changzhi, China.

shanxi zhendong pharmaceut-a (300158) Top Compensated Officers

Deputy General Manager and Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

shanxi zhendong pharmaceut-a (300158) Key Developments

Shanxi Zhendong Pharmaceutical Co.,Ltd Announces 2014 Final Distribution Plan, Payable on July 24, 2015

Shanxi Zhendong Pharmaceutical Co.,Ltd announced 2014 final distribution plan to be implemented (A shares) of cash dividend (tax included) of CNY 1.00000000 per ten shares. Payable on July 24, 2015 with record date of 23 July 2015 and ex-date of 24 July 2015.

Shanxi Zhendong Pharmaceutical Co.,Ltd Approves Amendment to the Articles of Association

Shanxi Zhendong Pharmaceutical Co.,Ltd announced at its Extraordinary General Meeting held on June 29, 2015, the shareholders approved the amendments to the company's articles of association.

Shanxi Zhendong Pharmaceutical Co.,Ltd Proposes Amendments to Articles of Association

Shanxi Zhendong Pharmaceutical Co.,Ltd proposed amendments to articles of association to be approve at the Extraordinary General Meeting of 2015 at on 29 June 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300158:CH CNY18.90 CNY 0.00

300158 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300158.
View Industry Companies
 

Industry Analysis

300158

Industry Average

Valuation 300158 Industry Range
Price/Earnings 100.0x
Price/Sales 2.8x
Price/Book 2.9x
Price/Cash Flow 136.3x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANXI ZHENDONG PHARMACEUT-A, please visit www.zdjt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.